🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHow far away are we really from an oral option — 12 month update Page 8

How far away are we really from an oral option — 12 month update

HPLC_Greg Wed, Jun 4, 2025 at 7:45 PM 47 replies 2,552 viewsPage 8 of 10
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
Jun 14, 2025 at 8:26 PM#36
newstart_MO said:
It helps to say which part of this you are uncertain about.

Coming at newstart_MO’s question from a different direction. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Last edited: Jun 15, 2025 at 1:26 AM
39 12mike_nyc, VendorMark, COA_Karl and 36 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Jun 15, 2025 at 9:01 AM#37

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Jun 15, 2025 at 10:01 AM
40 13DoseLogDan, SleepFixSam, PurityPaulOR and 37 others
Reply Quote Save Share Report
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Jun 15, 2025 at 9:35 PM#38

One thing that is still open after newstart_MO’s answer:

What would you measure differently if you were starting again?

Last edited: Jun 16, 2025 at 2:35 AM
41 14Dr.GutHealth, amsterdam_pete, LondonLisa and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
oliver_london
Member
312
1,345
Aug 2024
London, UK
Jun 16, 2025 at 10:09 AM#39
raj_cambridge said:
If you are going to change something, change one thing and give it long enough to express itself.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Last edited: Jun 16, 2025 at 11:09 AM
42 15jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 39 others
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Jun 16, 2025 at 10:43 PM#40
raj_cambridge said:
If you are going to change something, change one thing and give it long enough to express itself.

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

14 12dave_SLC, FDA_TrackerJim, ricardo_MIA and 11 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register